Jan 31, 2025 · HBV and HIV are bloodborne viruses transmitted primarily through sexual contact and sharing injection drug equipment. Because of these shared modes of transmission, a high proportion …

In population- and community-based studies, HCV antibody prevalence among PWID with HIV ranged from 10.7% to 71.4%, depending on the setting and study design.

Apr 21, 2026 · Infection with HCV is common among people with HIV and liver disease is accelerated by HIV coinfection. [3, 4] There are robust data that show modern, pangenotypic, direct-acting antiviral …

Degenhardt L, Peacock A, Colledge S, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: …

Jul 22, 2023 · The overlapping epidemics of hepatitis C virus (HCV) and HIV infection stem from underlying behaviors and health disparities among disproportionately affected populations, especially …

Mar 31, 2025 · Infection with both HIV and HCV is called HIV/HCV coinfection. Because both HIV and HCV can spread via blood, a major risk factor for both HIV and HCV infection is injection drug use. …

Mar 27, 2023 · Although sparse, available HIV and HCV incidence estimates offer insights into global levels of HIV and HCV transmission among PWID. Intensified efforts are needed to keep track of the …

Feb 26, 2026 · Evaluating trends in Hepatitis C virus (HCV) prevalence is critical for tracking the progress in HCV elimination efforts. We evaluated the changes in the prevalence of HCV infection …

The estimated prevalence of injection drug use was highest among males (2.1%; 95% CI, 1.1–4.2), non-Hispanic Whites (1.8%; 95% CI, .9–3.6), and adults aged 18–39 years (1.8%; 95% CI, .9–3.6).

Oct 1, 2025 · Characterizing acute and chronic hepatitis C virus (HCV) infection and HIV/HCV co-infection among persons who inject drugs (PWID) can inform eliminati…